Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women — Stella

Home/Pre-eclampsia/Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women

View on ClinicalTrials.gov

Recruiting

Back to Pre-eclampsia trials

Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Pakistan

Nishtar Medical University and Hospital, Multan, Punjab Province

Key details

Phase

Post-approval study

Sponsor

Nishtar Medical University

Enrollment target

~146 participants

Started

August 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 45 Years

Sex

Female only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.